Mary E. Godwin
CIK: 0001439716
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nautilus Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 23, 2024NAUT
Nautilus Biotechnology, Inc.
Exercise(M)Direct47K shares at avg. $0.46$22K - Sep 23, 2024NAUT
Nautilus Biotechnology, Inc.
Sale(S)Direct47K shares at avg. $2.87$135K - Sep 17, 2024NAUT
Nautilus Biotechnology, Inc.
Exercise(M)Direct35K shares at avg. $0.46$16K - Sep 17, 2024NAUT
Nautilus Biotechnology, Inc.
Sale(S)Direct35K shares at avg. $2.85$100K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | Exercise(M) | 47,031 | $0.46 | $21,634 | Direct |
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | Sale(S) | 47,031 | $2.87 | $134,744 | Direct |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | Exercise(M) | 35,000 | $0.46 | $16,100 | Direct |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | Sale(S) | 35,000 | $2.85 | $99,869 | Direct |
1-4 of 4 transactions
About Godwin Mary E.
Godwin Mary E. (SEC CIK 0001439716) files insider reports with the SEC as Senior VP, Operations of Nautilus Biotechnology, Inc. (NAUT).
Signal8 holds 2 ownership filings by Godwin Mary E., all Form 4s, filed between Sep 18, 2024 and Sep 25, 2024. Those filings report 4 transactions, from Sep 17, 2024 to Sep 23, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Godwin Mary E.'s filings is in SEATTLE, WA.
Recent filings by Godwin Mary E.
Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)
- Posard Matthew L., Director
- NAZEM FARZAD, Director
- Akinsanya Karen, Director
- McIlwain Matthew S, Director
- Epperly Melissa B,, Director
- AH Equity Partners Bio II, L.L.C., 10% Owner